Subscribe to our newsletter to learn in depth about our areas of expertise
Congresses
Biomol took part as a sponsor in the XX SEFIN Congress 2026. This scientific meeting focused on biological nitrogen fixation and beneficial interactions between plants and microorganisms. In addition, Fundación Instituto Biomol awarded three grants to support the attendance of young researchers. Last May, the XX SEFIN Congress 2026 was held in Cádiz. The event …
Biopsy
An integrated approach to improving molecular characterization, disease monitoring and clinical decision-making in oncology. Precision medicine has transformed the approach to cancer. It promotes the use of increasingly sensitive molecular tools to characterize disease, monitor progression and support clinical decision-making. In this context, the integration of liquid biopsy, pathology and oncohematology represents a key advance. …
Cámara de Comercio
April was a highly active period for Biomol. In this Biomol April 2026 activity review, we look back at the main corporate, scientific and business milestones that strengthened the company’s presence in the biomedical sector. On one hand, Biomol took part in leading national congresses. On the other hand, the company reinforced its relationship with …
Biomedicine
Liquid biopsy has become a key tool in translational oncology. While cfDNA analysis is already widely used, circulating tumor cells (CTCs) provide a more complex and informative sample. These cells are intact and viable, allowing real-time genomic, transcriptomic, proteomic, and functional analysis. However, their low frequency in peripheral blood (1–10 cells per mL) remains a …
Corporate
Biomol participated in the event “Applied AI: Strategy and Results”, organized by Loyola University Andalucía and the Sevilla FC Business Club, a meeting focused on analyzing how artificial intelligence applied to business is transforming corporate strategy, innovation and decision-making in organizations. Held at the Loyola University campus in Seville, the event brought together professionals, companies …
Biomedicine
Semiconductor-based NGS sequencing At Biomol, we work to make next-generation sequencing (NGS) easier to implement and simpler to scale. Ion Torrent technology is based on direct detection using a semiconductor chip, resulting in an agile, robust workflow that is particularly practical for research and clinical research laboratories. Ion Torrent performs sequencing by detecting the pH …
Cámara de Comercio
The company reinforces its role within the Cámara Antares Club following an institutional meeting with its President, Francisco Herrero León Biomol recently took part in an institutional meeting with Francisco Herrero León, President of the Seville Chamber of Commerce. The company was represented by its CEO, Rafael Estévez, and its President and Founder, Ángel Alcalde, …
Corporate
The new facility at the Faculty of Health Sciences drives applied research, education, and specialized scientific infrastructure. Loyola University and the Instituto Biomol Foundation have strengthened their strategic collaboration with the inauguration of a new research laboratory at the Faculty of Health Sciences on the Seville campus. This initiative is part of the extension of …
Corporate
A day dedicated to recognising the social impact of science communication and the value of bringing science closer to society On 17 December, the Andalusian Centre for Developmental Biology (CABD), together with Biomol, hosted the 2nd Edition of the Science Communication Awards, an event aimed at recognising individuals and projects that help bring scientific knowledge …
Biomedicine
Transgenic animals have become an essential tool in biomedical research, making a decisive contribution to our understanding of diseases and basic cellular processes. Today, pronuclear or cytoplasmic microinjection remains one of the most widely used methods for genome editing and the production of animal models.In this context, the micromanipulation system and the inverted microscope are …
